Biotechnology ‘investment visionary’ to speak at Illinois

CHAMPAIGN, Ill. – A longtime leader and promoter of biotechnology will speak about the potential for state and regional development of the industry at 2 p.m. Wednesday (March 17) at the University of Illinois at Urbana-Champaign.

G. Steven Burrill, chief executive officer of Burrill & Co., will speak in Room 102B of the Chemical and Life Sciences Lab, 601 S. Goodwin Ave., Urbana. His talk, “Biotechnology 2004: A State and Regional Perspective for Bioeconomic Development,” is free and open to the public. The Institute for Genomic Biology and the Office of the Vice President for Technology and Economic Development are sponsors of the event.

Burrill founded Burrill & Co., a San Francisco-based private merchant bank dedicated to the life sciences, in 1994. For the previous 28 years he had represented Ernst & Young’s financial services with clients in the areas of life sciences and high technology. In 2002, Scientific American recognized Burrill as “biotechnology’s investment visionary.”

He currently is chairman of the board for Paradigm Genetics and Pyxis Genomics and is the author of several articles and books that focus on the field of biotechnology.

Twelve Illinois scientists rank among the world’s most influential

CHAMPAIGN, Ill. — Twelve scientists at the University of Illinois Urbana-Champaign have been named to the 2025 Clarivate Analytics Highly Cited Researchers list. The list recognizes researchers and social scientists who have demonstrated exceptional influence, as reflected through their publication of multiple papers frequently cited by their peers during the last decade. The highly cited […]

Engineering A tilted view of miscellaneous of multicolored used batteries.

Study shows new hope for commercially attractive lithium extraction from spent batteries

A new study shows that lithium — a critical element used in rechargeable batteries and susceptible to supply chain disruption — can be recovered from battery waste using an electrochemically driven recovery process. The method has been tested on commonly used types of lithium-containing batteries and demonstrates economic viability with the potential to simplify operations, minimize costs and increase the sustainability and attractiveness of the recovery process for commercial use.

Health and Medicine Research team in the lab.

Study: A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy

CHAMPAIGN, Ill. — A naturally occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of some anticancer agents, including doxorubicin, one of the most widely used chemotherapies, and a preclinical drug known as ErSO, researchers report. The protein, FGD3, contributes to the rupture of cancer cells disrupted […]

Read Next

Twelve Illinois scientists rank among the world’s most influential

Study shows new hope for commercially attractive lithium extraction from spent batteries

Study: A cellular protein, FGD3, boosts breast cancer chemotherapy, immunotherapy